Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Transthyretin Amyloid Cardiomyopathy Early Detection With Artificial Intelligence (TRACE-AI) Network Study

NCT07062848 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07062848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07062848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Transthyretin Amyloid Cardiomyopathy Early Detection With Artificial Intelligence (TRACE-AI) Network Study
Lead sponsor
Yale University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 24, 2025
Completion date
January 31, 2027
Enrollment
Not reported
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin (ttr) amyloid cardiomyopathy